ADMA News and Press, ADMA Biologics Inc From 11/06/25

2025-11-06 03:31:51 ET More on ADMA Biologics ADMA Biologics, Inc. (ADMA) Q3 2025 Earnings Call Transcript ADMA Biologics: Strong Product Mix, Growing Margins And Compelling Upside ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform ...

2025-11-06 03:31:09 ET ADMA Biologics, Inc. (ADMA) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Adam Grossman - Co-Founder, President, CEO & Director Brad Tade - CFO & Treasurer ... Read the full article on Seeking Alpha ...

2025-11-05 16:39:03 ET More on ADMA Biologics ADMA Biologics: Strong Product Mix, Growing Margins And Compelling Upside ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform ADMA Biologics: A Better Quarter Than Headline Numbers ADMA...

3Q 2025 Total Revenue of $134.2 Million, a 12% YoY Increase 3Q 2025 GAAP Net Income of $36.4 Million, a 1% YoY Increase 3Q 2025 Adjusted EBITDA (1) of $58.7 Million, a 29% YoY Increase 3Q 2025 Adjusted Net Income (2) of $38.9 Million, an 8% YoY Incr...

Curaleaf Holdings Inc (CURLF) is expected to report $-0.07 for Q3 2025 Southwest Gas Holdings Inc. (DE) (SWX) is expected to report $0.09 for Q3 2025 Terreno Realty Corporation (TRNO) is expected to report $0.65 for Q3 2025 Bio-Techne Corp (TECH) is expected to report $0.36 for Q1 202...

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, t...

2025-10-15 14:30:32 ET My regular readers know that I am not sanguine on the overall market, which I articulated again on Tuesday . Almost one quarter of my portfolio is in short-term treasuries and cash. The rest of my portfolio is almost entirely in covered call positions arou...

2025-09-03 06:12:48 ET Intro ADMA Biologics (NASDAQ: ADMA) is a vertically integrated U.S. Immune Globulin (referred to as IG) plasma manufacturer whose earnings are growing due to two main factors that it directly controls: higher finished-goods yield from each liter of plasma and a mi...

2025-08-28 07:00:00 ET Market Update Read the full article on Seeking Alpha For further details see: Baird Small/Mid Cap Growth Equity Fund Q2 2025 Commentary

2025-08-10 09:15:00 ET ADMA Biologics Overview Read the full article on Seeking Alpha For further details see: ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform